USPTO serial 98859533
PATHLIGHT
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- SCHRADER, BRITTANY A
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with PATHLIGHT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kimberly B. Herman
Kimberly B. Herman Sullivan & Worcester LLPOne Post Office SquareBoston, MA 02109United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic preparations and materials being diagnostic agents and substances for medical purposes; biochemical preparations for the treatment of cancer; biological preparations for the treatment of cancer; chemical preparations for the treatment of cancer; chemical preparations for veterinary purposes, specifically for the treatment of cancer; nucleic acid sequences for medical and veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; reagents for medical use | ACTIVE | — |
| 042 | Analytical medical research laboratory services; blood analysis services for scientific research purposes; consultancy in the field of scientific research; contract research services relating to molecular sciences; design and development of medical technology being diagnostic tests and cancer monitoring tests; laboratory services namely DNA testing services to determine paternity; genetic scientific research; research laboratory analysis services in the field of bacteriology; laboratory research in the field of gene expression; medical research laboratories; laboratory services for analytical testing of biological material such as DNA and RNA; laboratory testing of materials in the field of genetics and genetic engineering; provision of information relating to scientific research; research and development in the field of biotechnology; research laboratory analysis services in the pharmaceutical and biotechnology fields; scientific laboratory services; scientific research; scientific research and analysis in the field of genetics and genetic engineering; scientific research for medical purposes; scientific research conducted using databases; scientific services, namely scientific laboratory services; scientific testing services in the field of genetics and genetic engineering; medical and pharmacological research services | ACTIVE | — |
| 044 | Human healthcare services in the field of oncology testing and detection and treatment of molecular residual disease; medical services in the field of oncology testing and detection and treatment of molecular residual disease; genetic counseling; genetic testing of animals for diagnostic or treatment purposes; health care services offered through a network of health care providers on a contract basis in the field of oncology testing and detection and treatment of molecular residual disease; cancer screening services; laboratory analysis services relating to the treatment of persons provided by medical laboratories; medical and healthcare clinics in the field of oncology testing and detection and treatment of molecular residual disease; medical and healthcare services in the field of oncology testing and detection and treatment of molecular residual disease; medical services, namely monitoring of patients; pathology services, namely, analysis services, diagnostic services and monitoring services for studying diseases; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; blood analysis services being medical analysis services for diagnostic treatment purposes provided by medical laboratories | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 16, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 15, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 15, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 15, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 3, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 7, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 4, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 4, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 4, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 21, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Aug 21, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| May 21, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 26, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 18, 2024 | NWAP | NEW APPLICATION ENTERED | — |